BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11410518)

  • 21. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
    Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
    Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
    Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
    Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
    Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
    Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse.
    Kim J; Hwang ES; Kim JS; You EH; Lee SH; Lee JH
    Cancer Gene Ther; 1999; 6(2):172-8. PubMed ID: 10195884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma.
    Mujoo K; Maneval DC; Anderson SC; Gutterman JU
    Oncogene; 1996 Apr; 12(8):1617-23. PubMed ID: 8622881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.
    Patel SD; Tran AC; Ge Y; Moskalenko M; Tsui L; Banik G; Tom W; Scott M; Chen L; Van Roey M; Rivkin M; Mendez M; Gyuris J; McArthur JG
    Mol Ther; 2000 Aug; 2(2):161-9. PubMed ID: 10947944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C; Lemmon M; Kirn D
    Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
    Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
    Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
    Rui HB; Su JZ
    Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
    Campbell I; Magliocco A; Moyana T; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Sep; 7(9):1270-8. PubMed ID: 11023200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biologic effects of introduction of wild-type p53 cDNA into a human ovarian cancer cell line SKOV-3].
    You Z; Guo Y; Cao Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):715-7. PubMed ID: 9772432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.